This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-347182-oj3v1x99 | COVID-19, i casi in Italia Coronavirus testing: how are the hardest- hit countries responding? |
| cord-343449-4uxwojzo | Have deaths from COVID-19 in Europe plateaued due to herd immunity? |
| cord-343449-4uxwojzo | Hypoxia- induced inflammation in the lung: a potential therapeutic target in acute lung injury? |
| cord-347353-ll2pnl81 | Why is Iran's reported mortality rate for coronavirus higher than in other countries? |
| cord-291975-y8ck4lo8 | Provided that there was a defined place with more than 364.000 people, and provided at that place everybody knew what COVID-19 is, will not miss a single death, will take care of people coughing, and provided that there was enough testing capacity at hand: Could it be that my formula( 5) to correct for selecting more morbid persons into a test pool, will also correct for all other sorts of selection bias, therefore delivering an ultra- precise early estimate for mortality? |
| cord-303991-pjycxlse | Covid-19 mortality is negatively associated with test number and government effectiveness Have testing charges affected the number of Covid-19 tests in Bangladesh? |
| cord-000916-b22s00es | The role of population heterogeneity and human mobility in the spread of pandemic influenza Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania |
| cord-285546-5tjhdczt | A cross- sectional study Korean Society of Infectious Diseases; Korean Society of Pediatric Infectious Diseases Report on the epidemiological features of coronavirus disease 2019( COVID-19) outbreak in the Republic of Korea from A German Exception? |
| cord-266989-n040i865 | Covid-19-a once- in- a- century pandemic? |
| cord-266989-n040i865 | HIV-1 gp120 and Gag Study claiming new coronavirus can be transmitted by people without symptoms was flawed How many people might one person with coronavirus infect? |
| cord-342996-honeavwj | CRD's guidance for undertaking reviews in health care Influenza vaccination for immunocompromised patients: systematic review and meta- analysis from a public health policy perspective Use of serum in the treatment of influenza- pneumonia Treatment of influenza with injections of blood from convalescents Treatment of influenza pneumonia with serum from convalescents Treatment of influenza pneumonia by use of convalescent human serum Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-342996-honeavwj | Serum treatment of postinfluenzal bronchopneumonia Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Treatment of Severe Pandemic Influenza A/ H1N1 Infection Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product? |
| cord-281508-zl2url8z | Does having diabetes or a high BMI, for example, involve a specific biological change( analogous to those observed for cancer and ALS) which is an intrinsic part of the process leading to Covid-19 mortality? |
| cord-281508-zl2url8z | If this is the case, are these conditions clearly- defined'steps'which can potentially be identified? |
| cord-281508-zl2url8z | If we can assume that the findings presented here are valid, given all the uncertainties of the data, what do they mean? |
| cord-281508-zl2url8z | On the other hand, are these conditions, like age, just markers of more general increases in immune- related susceptibility which accumulate across the life- course? |
| cord-281508-zl2url8z | The health of populations: general theories and particular realities Is social capital the key to inequalities in health? |
| cord-281508-zl2url8z | authors: Pearce, N.; Moirano, G.; Maule, M.; Kogevinas, M.; Rodo, X.; Lawlor, D.; Vandenbroucke, J.; Vandenbroucke- Grauls, C.; Polack, F. P.; Custovic, A. title: Is death from Covid-19 a multistep process? |
| cord-354133-11b0d499 | An interesting question is, at what point in the outbreak does the CFR calculated using the TSD analysis give a good approximation to the final value? |
| cord-354133-11b0d499 | How accurate are Australia's coronavirus numbers? |
| cord-354133-11b0d499 | What do these parameters represent? |
| cord-279539-s2zv7hr4 | Emerg Infect Dis New York Officials Traced More Than 50 Coronavirus Cases back To One Attorney Virtually perfect? |
| cord-258235-khdyxiwe | ( b) What are the probable causal variables that have significant impacts on the case fatality rates for the profoundly affected countries? |
| cord-258235-khdyxiwe | Can we generate real- time forecasts of daily new COVID-19 cases for countries like Canada, France, India, South Korea, and the UK? |
| cord-354073-tn76muv6 | Are coronavirus diseases equally deadly? |
| cord-354073-tn76muv6 | How deadly is this? |
| cord-354073-tn76muv6 | What objectively observed criteria of these COVID-19 situations are required for classification and visualization? |
| cord-354073-tn76muv6 | and( 2) how many people will die in this outbreak? |
| cord-330742-m5xx8861 | The gendered dimensions of COVID-19 Disparities in age- specific morbidity and mortality from SARS- CoV-2 in China and the Republic of Korea Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-338184-899km704 | 2020.00185/ full#supplementary- material Time to use the p- word? |
| cord-338184-899km704 | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-338184-899km704 | what next? |
| cord-336115-7ykvl3u6 | Can healthcare workers reasonably question the duty to care whilst healthcare institutions take a reactive( rather than proactive) approach to infectious disease risks? |
| cord-336115-7ykvl3u6 | Determinants of intravillage spread other than acquired immunity Smallpox: ten years gone From cooperation to competition in national health systems- and back? |
| cord-336115-7ykvl3u6 | Differences in influenza seasonality by latitude, northern India Chronological, geographical, and seasonal trends of human cases of avian influenza A( H5N1) in Vietnam, 2003- 2014: a spatial analysis Jenner and the history of smallpox and vaccination Infections and public health: who will win? |
| cord-336115-7ykvl3u6 | Will COVID-19 decline in the northern summer following the pattern of influenza? |
| cord-336115-7ykvl3u6 | Will the profits of multinational companies come before the survival of the poor in lower income countries 28? |
| cord-291400-o9skj94r | Are there interactions between the two antibiotics against Streptococcus pneumoniae? |
| cord-291400-o9skj94r | Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community- acquired pneumonia Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community- acquired pneumonia in Spain Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations Bacteremic pneumococcal pneumonia mortality rate: is it really different in Sweden? |
| cord-291400-o9skj94r | Correlation with in vitro resistance, antibiotics administered, and clinical outcome Is azithromycin the first- choice macrolide for treatment of community- acquired pneumonia? |
| cord-291400-o9skj94r | Is anti- tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia? |
| cord-291400-o9skj94r | The best treatment of pneumonia: new clues, but no definitive answers What is optimal therapy for bacteremic pneumococcal pneumonia? |
| cord-291400-o9skj94r | What is needed in the future? |
| cord-291400-o9skj94r | What is the possibility that the immune- modulating activity of macrolides is important in reducing the mortality rate? |
| cord-291400-o9skj94r | What is the possibility that the macrolide is treating a secondary infection in a patient with pneumococcal bacteremia? |
| cord-291400-o9skj94r | Why do some countries have many cases of nosocomial S pneumoniae infections[ 7] and others( eg, the United States) have a minimal number of such cases[ 27]? |
| cord-291400-o9skj94r | Why does the CFR differ among different centers and countries[ 40, 41]? |
| cord-291400-o9skj94r | Why would a b- lactam( cephalosporin) in combination with a macrolide be more efficacious than a b- lactam( cephalosporin) alone in the treatment of patients with bacteremic pneumococcal pneumonia? |
| cord-291400-o9skj94r | Would the use of two empiric antibiotics make it more likely that at least one would be active against the pneumococcus? |
| cord-349978-zklwovba | ( Does this assumption even matter if we are in the branching- process regime?). |
| cord-349978-zklwovba | Could the authors comment on how much extra mileage one gets/ advantages of this approach relative to simply saying that the current number of cases is approximately equal to 1/ CFR? |
| cord-349978-zklwovba | Does this mean that you assume that all observed deaths are from separate lineages/ transmission chains? |
| cord-349978-zklwovba | If any results are presented, are all the source data underlying the results available to ensure full reproducibility? |
| cord-349978-zklwovba | In tables 1 and 2 consider stating"2.5% quantile, 25% quantile, 50% quantile, 97.5% quantile"( rather than lower/ upper x 95%/50%)? |
| cord-349978-zklwovba | Intro, line 1; methods, l. 7: extra comma inside parens before superscript refs?) |
| cord-349978-zklwovba | Is the description of the method technically sound? |
| cord-349978-zklwovba | It's not completely obvious to me how to get from there to'history of past cases'( i.e. incidence over time); does one run the renewal process backward in time? |
| cord-349978-zklwovba | Or use branching- process theory to find the time distribution of symptom onset of the index case given the current size of the epidemic? |
| cord-349978-zklwovba | That is, does one have to reconstruct the past history to know how much trouble one is currently in? |
| cord-349978-zklwovba | What would the effect of a heterogeneous CFR be? |
| cord-349978-zklwovba | the conclusions about the method and its performance adequately supported by the findings presented in the article? |
| cord-349978-zklwovba | to reconstruct the past history to know how much trouble one is currently in? |